Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
NFE2L2 overexpression
i
Other names:
NFE2L2, Nuclear Factor Erythroid 2 Like 2, Nuclear Factor Erythroid 2-Related Factor 2, NF-E2-Related Factor 2, HEBP1, Nrf-2, NRF2, Nuclear Factor Erythroid Derived 2 Like 2, Nuclear Factor (Erythroid-Derived 2)-Like 2, Nuclear Factor Erythroid-Derived 2-Like 2, Nuclear Factor Erythroid 2-Like 2, NFE2-Related Factor 2, IMDDHH
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4780
Related biomarkers:
Expression
Mutation
‹
NFE2L2 mutation (7)
NFE2L2 E79K (1)
NFE2L2 mutation + CTNNB1 mutation (1)
NFE2L2 mutation + STK11 mutation (1)
KEAP1 mutation + NFE2L2 mutation + STK11 mutation (0)
NFE2L2 mutation (7)
NFE2L2 E79K (1)
NFE2L2 mutation + CTNNB1 mutation (1)
NFE2L2 mutation + STK11 mutation (1)
KEAP1 mutation + NFE2L2 mutation + STK11 mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
NFE2L2 overexpression
Hepatocellular Cancer
NFE2L2 overexpression
Hepatocellular Cancer
sorafenib
Resistant: C3 – Early Trials
sorafenib
Resistant
:
C3
sorafenib
Resistant: C3 – Early Trials
sorafenib
Resistant
:
C3
NFE2L2 overexpression
Acute Myelogenous Leukemia
NFE2L2 overexpression
Acute Myelogenous Leukemia
cytarabine
Resistant: D – Preclinical
cytarabine
Resistant
:
D
cytarabine
Resistant: D – Preclinical
cytarabine
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.